CompletedNot Applicable

Diabetes, Falls, and Fractures

Denmark110 participantsStarted 2022-05-06

Plain-language summary

Comparing severity of diabetic peripheral neuropathy (small and large fibers including autonomic neuroapthy) to postural control and vestibular measurements

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Men and women with minimum 40 years of age and maximum 70 years of age.
✓. Diagnosis of T1D or T2D
✓. Diagnosis of diabetes with at least one year prior to inclusion of the study
✓. Signed the informed consent.

Exclusion criteria

✕. Severe decreased liver function (Alanin amino-transaminase (ALAT)\>250u/l, GammaGlutamyltransferase (GGT)\>150u/l)
✕. Moderate to severe kidney dysfunction, estimated Glomerular Filtration Rate (eGFR) \<15mmol/L/1,73m2
✕. Pregnancy or breast feeding
✕. Active malignancy or terminal ill.
✕. Current or previous alcohol- or drug abuse

What they're measuring

Co-existence of peripheral- and vestiubular neuropathy in people with diabetes

Timeframe: through study completion, an average of 2 years

Co-existence of peripheral neuropathy and impaired dynamic postural control in people with diabetes

Timeframe: through study completion, an average of 2 years

Trial details

NCT IDNCT05389566

SponsorAalborg University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-20

View on ClinicalTrials.gov More Diabetic Peripheral Neuropathy trials